ARYD Stock Overview
Arya Sciences Acquisition Corp IV does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ARYA Sciences Acquisition Corp IV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.35 |
| 52 Week High | US$11.39 |
| 52 Week Low | US$10.41 |
| Beta | -0.0016 |
| 1 Month Change | 0.80% |
| 3 Month Change | 2.99% |
| 1 Year Change | 8.93% |
| 3 Year Change | 2.99% |
| 5 Year Change | n/a |
| Change since IPO | 1.98% |
Recent News & Updates
Shareholder Returns
| ARYD | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0.4% | 2.6% | 1.2% |
| 1Y | 8.9% | 31.6% | 24.9% |
Return vs Industry: ARYD underperformed the US Capital Markets industry which returned 31.9% over the past year.
Return vs Market: ARYD underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| ARYD volatility | |
|---|---|
| ARYD Average Weekly Movement | 0.6% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ARYD has not had significant price volatility in the past 3 months.
Volatility Over Time: ARYD's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Adam Stone | www.perceptivelife.com/arya4 |
Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.
ARYA Sciences Acquisition Corp IV Fundamentals Summary
| ARYD fundamental statistics | |
|---|---|
| Market cap | US$89.98m |
| Earnings (TTM) | -US$2.13m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-42.2x
P/E RatioIs ARYD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARYD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.13m |
| Earnings | -US$2.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -14.7% |
How did ARYD perform over the long term?
See historical performance and comparison